CD163 and neoplasm: No significant correlation was found with the tumour stage and expression of CD163, CD90 and PDPN in this cohort (CD90, r=0.04, p=0.9; PDPN, r = -0.4, p=0.19; CD163, r=0.27, p=0.43).